Quantcast

Amidst Research Output Growth in India, Opportunities Abound to Generate Greater Impact, Reveals Elsevier Report

March 3, 2014

NEW DELHI, March 3, 2014 /PRNewswire/ –

2013 study throws light on India’s performance as benchmarked against other

research nations

A recent study [http://info.scival.com/research-initiatives/BIS2013 ] prepared by
Elsevier [http://www.elsevier.com ] for the UK’s Department of Business, Innovation and
Skills (BIS) and based on Scopus data, shows that India has achieved substantial growth in
research articles output, increasing from 54 thousand in 2008 to 93 thousand in 2012 at an
annualized growth rate of 14.4%. This is a rate higher than that of China (10.9%), Brazil
(7.9%), Russia (1.9%) and the U.K. (2.9%).

(Photo:
http://photos.prnewswire.com/prnh/20140303/673420 )

Figure: Share of world articles for the UK and comparators Brazil, India, Russia,
2008-2012 with right-hand panel excluding the US and China for clarity. Source: Scopus.

Over the same period from 2008 to 2012, India’s share of the top 10% of the most cited
articles – a proxy for high quality research articles – rose from 2.0% to 3.1% at an
annual growth rate of 11.3%, which is higher than Brazil (7.6%), Russia (8.4%) and the
U.K. (- 2.7%). Only China surpassed India with a 13.8% annual growth rate.

India’s field-weighted citation impact (FWCI) – normalized at value of “1″ as the
world average – is below average at 0.75 and is declining at a rate of 1.6% per year.
China has a comparable FWCI to India, but is experiencing an upward annual growth rate of
2.4%. The field-weighted citation impact is generally considered to be a good indicator
for quality.

The report indicates that when India collaborates internationally, the articles with
Indian and international co-authors are associated with 111% greater FWCI than articles
with single institution co-authorship.

India’s international co-authorship is modest with a share of 16.2% in 2012, behind
Brazil (24.2%), Russia (29.8%) and the U.K. (47.6%). Only China’s international co-author
share is below India’s at 14.9%.

Dr. Michiel Kolman, Senior Vice-President of Academic Relations at Elsevier, who is
visiting Mumbai, New Delhi and Bangalore, said, “India shows incredible growth in article
output, even surpassing China. On the quality side, although we see an overall impact that
is below the world’s average, there is a rising share of higher-quality articles from
India. Articles from India that resulted from international collaboration show
impressively high quality at more than twice the impact of articles from a single
institute.”

“More can be done to further advance India’s research excellence. Encouraging
collaboration with the international research community will aid knowledge transfer
between parties and bolster cross-border recognition,” said Dr. Kolman.

On India’s performance in patents, the number of patents granted to India in 2012 is
3588, a figure that is higher than Brazil’s (1027), but considerably lower than the
numbers for the U.K. (20,194), Russia (24,551) and much farther behind China (152,102).

Dr. Kolman also revealed that the proportion of Indian research cited in patents is
relatively low. The relative share of India’s patent citations to articles published from
2007 to 2011 is at 1.50 for the UK, and generally lower amongst the BRIC countries: India
(0.65), China (0.54), Russia (0.42) and Brazil (0.44).

Dr. Kolman went on to explain that many U.K. research articles have been cited in
worldwide patents. “This indicates that the U.K. possesses the infrastructure and
governance to produce research that lays the foundation for innovation. In India and other
BRIC nations (Brazil, Russia and China), there are room and opportunities for greater
growth in both the number of patents and the research that leads to patents.”

About Scopus

Scopus [http://www.scopus.com ], the largest abstract and citation database of
peer-reviewed literature, features smart tools to track, analyze and visualize scholarly
research. Its vast database contains abstracts and references from 21,000 titles from more
than 5,000 publishers worldwide, ensuring broad interdisciplinary coverage in the fields
of science, technology, medicine, social sciences and Arts & Humanities. Scopus was
designed and developed with input from researchers and librarians internationally; and
features direct links to subscribed full-text articles, other library resources and
interoperability with applications such as reference management software.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information
products and services. The company works in partnership with the global science and health
communities to publish more than 2,000 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and 25,000 book titles,
including major reference works from Mosby and Saunders. Elsevier’s online solutions
include ScienceDirect [http://www.sciencedirect.com ], Scopus [http://www.scopus.com ],
SciVal [http://info.scival.com ], Reaxys [http://www.elsevier.com/reaxys ], ClinicalKey
[https://www.clinicalkey.com ] and Mosby’s Suite [http://www.confidenceconnected.com ],
which enhance the productivity of science and health professionals, helping research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier [http://www.elsevier.com ]
employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC
[http://www.reedelsevier.com ], a world leading provider of professional information
solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly
owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

        Media contact
        Jason Chan
        Director, Corporate Relations, Asia Pacific
        Elsevier
        +65-63490240
        j.chan@elsevier.com


    Photo: 

http://photos.prnewswire.com/prnh/20140303/673420

SOURCE Elsevier


Source: PR Newswire



comments powered by Disqus